Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus

Author: Miller Shannon A   St. Onge Erin  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.11, Iss.11, 2011-11, pp. : 1525-1532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract